Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

Share Price is delayed by 15 minutes
Get Live Data
23.50    0.00 (0.00%)
Bid:
23.00
Ask:
24.00
Spread: 1.00 (4.348%)
Market Cap: £11.19m
PEN Live PriceLast checked at - London Stock Exchange

Intraday Pennant International Share Chart

Total Voting Rights

1 Oct 2025 09:39

RNS Number : 6120B
Pennant International Group PLC
01 October 2025
 

 

FOR IMMEDIATE RELEASE 01 October 2025

 

PENNANT INTERNATIONAL GROUP PLC

("Pennant", the "Company" and together with its subsidiaries the "Group")

 

Total Voting Rights

In compliance with the FCA's Disclosure Guidance and Transparency Rules, the Company announces that, as at the date of this announcement, it has 47,557,533 Ordinary Shares in issue admitted to trading on AIM.

The Company has no Ordinary Shares in Treasury. The total number of voting rights in the Company is therefore 47,557,533 and all Ordinary Shares have equal voting rights. 

Accordingly, the figure of 47,557,533 may be used by shareholders for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules.

Enquiries:

  

Pennant International Group plc

www.pennantplc.com

David Clements, Company Secretary

+44 (0) 1452 714 914

Cavendish (Nominated Adviser and Sole Broker)

www.cavendish.com

Ben Jeynes / Callum Davidson / George Lawson

(Corporate Finance)

+44 (0) 207 220 0500

Michael Johnson / Dale Bellis / Sunila de Silva

(Sales and Corporate Broking) 

Walbrook PR (Financial PR)

pennant@walbrookpr.com

Tom Cooper

Joe Walker

+44 (0)20 7933 8780

Mob: +44 (0)7407 020 470

 

Notes to editors:

Pennant International Group plc (AIM: PEN) is a technology driven, leading global provider of system support software and services, technical services, and training solutions. It supports its global customer base in the design, development, operation, maintenance, and training of complex assets, to maximise operational and maintenance efficiency.

 

Its key markets include Aerospace, Defence and Rail, and adjacent safety-critical markets such as Shipping, Nuclear and Space.

 

 The Group addresses the market through three key business segments:

 

• Auxilium software: a key generator of recurring revenues through the provision of a suite of software tools designed to help clients: manage and use complex data; ensure equipment availability at optimal cost; and comply with industry standards. Its Integrated Product Support (IPS) and Integrated Logistics Support (ILS) software and services equips customers with powerful market-leading toolsets to manage, model and utilise complex equipment data.

 

• Technical Services: drives repeatable revenues through expert support for users of Pennant and third-party solutions including consultancy, support and maintenance, training and bespoke development.

 

• Training Systems: project-based revenues relating to the design and build of hardware, software and virtual training solutions for maintainers and operators of aircraft, ships and land systems.

 

Pennant is strategically focused on sustainable recurring and repeatable revenues and profitability growth, shifting its model towards high margin software and services. Against a climate of rising defence budgets and the burgeoning technological complexity of military, aviation and rail platforms, the demand for these solutions is expected to grow substantially.

 

Headquartered in Cheltenham, UK, the Group operates worldwide, with offices in the UK, North America and Asia-Pacific, serving markets with high barriers to entry often in regulated industries.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRFZMGGRMKGKZG
Date   Source Headline
4th Jun 20267:00 amRNS-RLaunch of Auxilium Phase 3
20th May 20263:18 pmRNSHolding(s) in Company
19th May 20267:20 amRNS-R1st conversion services contract & Siemens update
14th May 20267:00 amRNSDirector dealing
13th May 20267:00 amRNSGrant of Options
11th May 20267:00 amRNSTraining Systems Contract Win
8th May 202611:56 amRNSResult of AGM
21st Apr 20262:05 pmRNSHolding(s) in Company
1st Apr 20262:54 pmRNSNotice of AGM & Posting of Accounts
31st Mar 20265:00 pmRNSTotal Voting Rights
26th Mar 20267:00 amRNSIssue of Equity
23rd Mar 20267:00 amRNSFinal Results & Notice of Investor Presentation
2nd Feb 20267:00 amRNSTraining Systems Contract Win
19th Jan 20267:00 amRNSTrading & Strategy Update, Notice of Results
15th Jan 20267:00 amRNSDirectorate change
12th Dec 20253:34 pmRNSDirector Dealing
1st Dec 20251:36 pmRNSDirector Dealing
27th Nov 20259:40 amRNSHolding(s) in Company
25th Nov 202512:40 pmRNSGenFly Contract Award - valued at up to £5.75m
24th Oct 202511:15 amRNSHolding(s) in Company
21st Oct 20257:00 amRNSShareholder Loan
8th Oct 202510:36 amRNSContract wins
1st Oct 20259:39 amRNSTotal Voting Rights
25th Sep 202512:59 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSSubscription update and closing & TVR
16th Sep 20257:01 amRNSProposed Underwritten Subscription to raise £1.25m
16th Sep 20257:00 amRNSInterim Results, Analyst Briefing & Investor Pres
14th Aug 20257:00 amRNSChange of Adviser
11th Aug 20253:01 pmRNSHolding(s) in Company
8th Aug 20257:00 amRNSTrading Update & Notice of Results
14th Jul 20257:00 amRNSGlobal Partner Appointed & Auxilium Presentation
3rd Jul 20257:00 amRNSBusiness Update
6th Jun 20251:08 pmRNSResult of AGM
8th May 202512:30 pmRNSNotice of AGM & Posting of Accounts
24th Apr 20257:00 amRNSFinal Results, Analyst Briefing & Investor Pres
9th Apr 20257:00 amRNSGenFly Contract Update
8th Apr 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
7th Apr 20257:00 amRNSProperty Disposal Programme Update
11th Mar 20252:25 pmRNSHolding(s) in Company
24th Feb 20257:00 amRNSProperty Disposal Programme Update
3rd Feb 20251:41 pmRNSDirector Dealings
16th Dec 202410:49 amRNSHolding(s) in Company
12th Dec 20247:00 amRNSAward of Options
10th Dec 20247:00 amRNSTrading Statement, Business Update & Investor Pres
20th Nov 20247:00 amRNSAppointment of CFO
14th Nov 20242:47 pmRNSHolding(s) in Company
6th Nov 20244:34 pmRNSHolding(s) in Company
23rd Oct 20243:56 pmRNSContracts Update
22nd Oct 20245:55 pmRNSHolding(s) in Company
10th Oct 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.